Characteristics of relapsing remitting multiple sclerosis patients as possible indicators of response to interferon beta-1b (IFN BETA-1b) treatment

被引：0
|
作者：
Duquette, P
HoudeSauve, M
Bedell, L
机构：
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3068 / 3068
页数：1
相关论文
共 50 条
  • [31] INTERFERON BETA-1B
    GOODKIN, DE
    [J]. LANCET, 1994, 344 (8929): : 1057 - 1060
  • [32] Comparison of the effect of interferon (IFN) beta-1b (Betaferon) and beta-1a (Rebif) on brain MRI lesions in patients with remitting-relapsing multiple sclerosis (RRMS)
    Sabet, Shafiee M.
    Fereshtehnejad, Seyed-Mohammad
    Motamed, Mohammad Reza
    Zamiri, Alaleh
    Najimi, Neda
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 71 - 71
  • [33] INTERFERON BETA-1B
    RUDGE, P
    [J]. LANCET, 1994, 344 (8935): : 1511 - 1511
  • [34] INTERFERON BETA-1B
    GOODKIN, DE
    [J]. LANCET, 1994, 344 (8938): : 1702 - 1703
  • [35] Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy
    Lanzillo, R.
    Orefice, G.
    Prinster, A.
    Ventrella, G.
    Liuzzi, R.
    Scarano, V.
    Florio, C.
    Vacca, G.
    Brunetti, A.
    Alfano, B.
    Morra, V. Brescia
    Bonavita, V.
    [J]. NEUROLOGICAL SCIENCES, 2011, 32 (02) : 287 - 292
  • [36] Serial magnetization transfer ratio imaging in relapsing-remitting multiple sclerosis patients: Effect of interferon beta-1b
    Richert, N
    Ostuni, J
    Duyn, J
    Bash, C
    Stone, L
    Lewis, B
    Maloni, H
    McFarland, H
    Frank, J
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (03) : M113 - M113
  • [37] Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy
    R. Lanzillo
    G. Orefice
    A. Prinster
    G. Ventrella
    R. Liuzzi
    V. Scarano
    C. Florio
    G. Vacca
    A. Brunetti
    B. Alfano
    V. Brescia Morra
    V. Bonavita
    [J]. Neurological Sciences, 2011, 32 : 287 - 292
  • [38] A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis
    Gulati, A.
    Bagnato, F.
    Villoslada, P.
    de Mendizabal, N. Velez
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (05): : 295 - 304
  • [39] Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b
    Borràs, C
    Río, J
    Porcel, J
    Barrios, M
    Tintoré, M
    Montalban, X
    [J]. NEUROLOGY, 1999, 52 (08) : 1636 - 1639
  • [40] Value of interleukin 1 polymorphisms as prognostic marker of efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis
    Garrote, J. A.
    Guerrero, A. L.
    Perez, D.
    Mendoza, A.
    Lopez-Alburquerque, J. T.
    Moran, J. C.
    Guerrero, A. B.
    Bernardo, D.
    Caminero, A. B.
    Martin-Polo, J.
    Merino, S.
    Alonso, H.
    Jimenez, C.
    Ruiz-Ezquerro, J. J.
    Arranz, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 488 - 488
12345